• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Receptor Tyrosine Kinases
    1 Drug classified under this drug class

    All the Drug Class Drugs

    Boehringer Ingelheim
    partial basket chart

    Non-Receptor Tyrosine Kinases Inhibitor, Receptor Tyrosine Kinases. Nintedanib (As Esliate) 100 mg, 150 mg.
    CAPS.: 100mg ×30, 60; 150mg ×60. Conduct liver funct. tests prior to init. tmt.
    The recom. dosage 150 mg×2/d admin. approx. 12 hrs. apart.
    Caps. should be taken with food and swallowed whole with liquid.
    Do not exceed the recom. max. dly. dosage of 300 mg. See lit.
    Tmt. of idiopathic pulmonary fibrosis (IPF) in adults.
    Systemic Sclerosis-Associated Interstitial Lung dis.
    Indicated to slow the rate of decline in pulmon. funct. in pts. with system. sclerosis associated interstitial lung dis. (SSc-ILD).
    C/I: Hypersens.